Market Cap 1.91B
Revenue (ttm) 74.68M
Net Income (ttm) -644.76M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -863.36%
Debt to Equity Ratio 0.01
Volume 28,502,649
Avg Vol 14,427,224
Day's Range N/A - N/A
Shares Out 529.91M
Stochastic %K 77%
Beta 1.04
Analysts Sell
Price Target $6.64

Company Profile

Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-12...

Industry: Biotechnology
Sector: Healthcare
Phone: 385 269 0203
Address:
41 South Rio Grande Street, Salt Lake City, United States
stockit111
stockit111 Jun. 4 at 6:16 PM
$RXRX Seems someone knows something.
0 · Reply
Lh2838
Lh2838 Jun. 4 at 6:15 PM
$RXRX REC 4881 (FDA Phase 3 ) news coming soon hopefully 🤞
0 · Reply
G101SPM
G101SPM Jun. 4 at 5:35 PM
#OPTIONACTION $RXRX Weekly Jun05 4 calls are seeing interest with the underlying stock 12% (volume: 10.1K, open int: 7.3K, implied vol: ~110%, prev day implied vol: 66%). 3.0K traded in a single transaction. Co is expected to report earnings mid-August. $OPEN Weekly Jun12 5 calls (volume: 1.3K, open int: 4.2K, implied vol: ~90%, prev day implied vol: 70%). Co is expected to report earnings late June. $TEM Weekly Jun12 55 calls are seeing interest with the underlying stock up 9% (volume: 5.8K, open int: 1.3K, implied vol: ~76%, prev day implied vol: 67%). Co is expected to report earnigs early August. $IBIT Weekly Jun12 36 puts (volume: 13.5K, open int: 6.3K, implied vol: ~44%, prev day implied vol: 40%). 12.5K traded in a single transaction. Co is expected to report earnings mid-August. $CMG Jun 27.5 puts (volume: 54.9K, open int: 61.4K, implied vol: ~39%, prev day implied vol: 37%). Nearly all the volume occurred in a single transaction. Co is confirmed to report earnings July 29 after the close.
0 · Reply
RodTidwell73
RodTidwell73 Jun. 4 at 5:20 PM
0 · Reply
Floridaorange
Floridaorange Jun. 4 at 5:16 PM
$RXRX The fact that healthcare is being specifically called out in a day when the Dow is up 900+ points is important for RXRX. If this develops into a sustained rotation rather than a one-day move, that’s the kind of backdrop where beaten-down biotech can go from being ignored to becoming a favored destination for new capital.
0 · Reply
Jayalvarez
Jayalvarez Jun. 4 at 4:59 PM
0 · Reply
Oceanavekid
Oceanavekid Jun. 4 at 4:47 PM
$RXRX 👀
0 · Reply
nly
nly Jun. 4 at 4:46 PM
$RXRX entered yesterday
0 · Reply
Floridaorange
Floridaorange Jun. 4 at 4:44 PM
$RXRX $VERU The future isn’t one blockbuster drug. The future is combinations. The industry is moving toward a world where finding and optimizing combinations matters as much as inventing the original drug—and that’s a world where large-scale AI biology platforms should have a structural advantage.
0 · Reply
LoveRetailFroth
LoveRetailFroth Jun. 4 at 4:42 PM
$RXRX If SpaceX is worth 2 TRILLION, this & $TEM should be worth atleast 100 Billion 😂
0 · Reply
Latest News on RXRX
Recursion to Participate in Upcoming Investor Conferences

Jun 2, 2026, 8:00 AM EDT - 2 days ago

Recursion to Participate in Upcoming Investor Conferences


Recursion Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Recursion Pharmaceuticals Earnings Call Transcript: Q1 2026


Recursion Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Recursion Pharmaceuticals Earnings release: Q1 2026


Recursion Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Recursion Pharmaceuticals Quarterly report: Q1 2026


Recursion Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 4 weeks ago

Recursion Pharmaceuticals Slides: Q1 2026


Recursion Announces Board Transition

Apr 30, 2026, 4:30 PM EDT - 4 weeks ago

Recursion Announces Board Transition


Recursion Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Recursion Pharmaceuticals Proxy statement: Proxy filing


Recursion Pharmaceuticals Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 5 weeks ago

Recursion Pharmaceuticals Proxy statement: Proxy filing


PacBio appoints Gibson to Board of Directors

2026-03-05T13:44:59.000Z - 3 months ago

PacBio appoints Gibson to Board of Directors

PACB


Recursion Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:00 AM EST - 3 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q4 2025


Recursion Pharmaceuticals Annual report: Q4 2025

Feb 25, 2026, 8:00 AM EST - 3 months ago

Recursion Pharmaceuticals Annual report: Q4 2025


Recursion Pharmaceuticals Earnings release: Q4 2025

Feb 25, 2026, 8:00 AM EST - 3 months ago

Recursion Pharmaceuticals Earnings release: Q4 2025


Recursion Pharmaceuticals Slides: Q4 2025

Feb 25, 2026, 8:00 AM EST - 3 months ago

Recursion Pharmaceuticals Slides: Q4 2025


Recursion Pharmaceuticals reports Q4 EPS (21c), consensus (32c)

2026-02-25T11:47:23.000Z - 3 months ago

Recursion Pharmaceuticals reports Q4 EPS (21c), consensus (32c)


Recursion Pharmaceuticals reports grant of inducement awards

2026-02-12T13:10:56.000Z - 4 months ago

Recursion Pharmaceuticals reports grant of inducement awards


What's Happening With RXRX Stock?

Dec 18, 2025, 11:05 AM EST - 6 months ago

What's Happening With RXRX Stock?


Recursion Pharmaceuticals Transcript: Study Update

Dec 8, 2025, 8:00 AM EST - 6 months ago

Recursion Pharmaceuticals Transcript: Study Update


Recursion Pharmaceuticals Press release: Study Update

Dec 8, 2025, 8:00 AM EST - 6 months ago

Recursion Pharmaceuticals Press release: Study Update


Recursion Pharmaceuticals Slides: Study Update

Dec 8, 2025, 8:00 AM EST - 6 months ago

Recursion Pharmaceuticals Slides: Study Update


Recursion Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q3 2025


Recursion Pharmaceuticals Quarterly report: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Quarterly report: Q3 2025


Recursion Pharmaceuticals Earnings release: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Earnings release: Q3 2025


Recursion Pharmaceuticals Slides: Q3 2025

Nov 5, 2025, 8:00 AM EST - 7 months ago

Recursion Pharmaceuticals Slides: Q3 2025


Recursion Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Recursion Pharmaceuticals Earnings Call Transcript: Q2 2025


Recursion Pharmaceuticals Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Recursion Pharmaceuticals Quarterly report: Q2 2025


Recursion Pharmaceuticals Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Recursion Pharmaceuticals Earnings release: Q2 2025


Recursion Pharmaceuticals Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 10 months ago

Recursion Pharmaceuticals Slides: Q2 2025


Recursion Pharmaceuticals Earnings Call Transcript: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Earnings Call Transcript: Q1 2025


Recursion Pharmaceuticals Quarterly report: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Quarterly report: Q1 2025


Recursion Pharmaceuticals Earnings release: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Earnings release: Q1 2025


Recursion Pharmaceuticals Slides: Q1 2025

May 5, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Slides: Q1 2025


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Apr 28, 2025, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion to Participate in Upcoming Investor Conference

Apr 1, 2025, 8:00 AM EDT - 1 year ago

Recursion to Participate in Upcoming Investor Conference


Recursion Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings Call Transcript: Q4 2024


Recursion Pharmaceuticals Annual report: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Annual report: Q4 2024


Recursion Pharmaceuticals Earnings release: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings release: Q4 2024


Recursion Pharmaceuticals Slides: Q4 2024

Feb 28, 2025, 8:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: Q4 2024


Altitude Lab Startups Raise $154M in Capital

Feb 18, 2025, 11:00 AM EST - 1 year ago

Altitude Lab Startups Raise $154M in Capital


Recursion Pharmaceuticals Slides: FY 2025

Jan 13, 2025, 10:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: FY 2025


Recursion Pharmaceuticals Transcript: Status Update

Dec 9, 2024, 7:00 PM EST - 1 year ago

Recursion Pharmaceuticals Transcript: Status Update


Recursion Pharmaceuticals Slides: Status Update

Dec 9, 2024, 7:00 PM EST - 1 year ago

Recursion Pharmaceuticals Slides: Status Update


Recursion Pharmaceuticals Transcript: Status Update

Nov 20, 2024, 7:30 AM EST - 1 year ago

Recursion Pharmaceuticals Transcript: Status Update


Recursion Pharmaceuticals Press release: Status Update

Nov 20, 2024, 7:30 AM EST - 1 year ago

Recursion Pharmaceuticals Press release: Status Update


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Nov 6, 2024, 7:00 AM EST - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Quarterly report: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Quarterly report: Q3 2024


Recursion Pharmaceuticals Earnings release: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Earnings release: Q3 2024


Recursion Pharmaceuticals Slides: Q3 2024

Nov 6, 2024, 2:30 AM EST - 1 year ago

Recursion Pharmaceuticals Slides: Q3 2024


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Oct 10, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 19, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 4, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Aug 28, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


Recursion Pharmaceuticals Proxy statement: Proxy Filing

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Recursion Pharmaceuticals Proxy statement: Proxy Filing


stockit111
stockit111 Jun. 4 at 6:16 PM
$RXRX Seems someone knows something.
0 · Reply
Lh2838
Lh2838 Jun. 4 at 6:15 PM
$RXRX REC 4881 (FDA Phase 3 ) news coming soon hopefully 🤞
0 · Reply
G101SPM
G101SPM Jun. 4 at 5:35 PM
#OPTIONACTION $RXRX Weekly Jun05 4 calls are seeing interest with the underlying stock 12% (volume: 10.1K, open int: 7.3K, implied vol: ~110%, prev day implied vol: 66%). 3.0K traded in a single transaction. Co is expected to report earnings mid-August. $OPEN Weekly Jun12 5 calls (volume: 1.3K, open int: 4.2K, implied vol: ~90%, prev day implied vol: 70%). Co is expected to report earnings late June. $TEM Weekly Jun12 55 calls are seeing interest with the underlying stock up 9% (volume: 5.8K, open int: 1.3K, implied vol: ~76%, prev day implied vol: 67%). Co is expected to report earnigs early August. $IBIT Weekly Jun12 36 puts (volume: 13.5K, open int: 6.3K, implied vol: ~44%, prev day implied vol: 40%). 12.5K traded in a single transaction. Co is expected to report earnings mid-August. $CMG Jun 27.5 puts (volume: 54.9K, open int: 61.4K, implied vol: ~39%, prev day implied vol: 37%). Nearly all the volume occurred in a single transaction. Co is confirmed to report earnings July 29 after the close.
0 · Reply
RodTidwell73
RodTidwell73 Jun. 4 at 5:20 PM
0 · Reply
Floridaorange
Floridaorange Jun. 4 at 5:16 PM
$RXRX The fact that healthcare is being specifically called out in a day when the Dow is up 900+ points is important for RXRX. If this develops into a sustained rotation rather than a one-day move, that’s the kind of backdrop where beaten-down biotech can go from being ignored to becoming a favored destination for new capital.
0 · Reply
Jayalvarez
Jayalvarez Jun. 4 at 4:59 PM
0 · Reply
Oceanavekid
Oceanavekid Jun. 4 at 4:47 PM
$RXRX 👀
0 · Reply
nly
nly Jun. 4 at 4:46 PM
$RXRX entered yesterday
0 · Reply
Floridaorange
Floridaorange Jun. 4 at 4:44 PM
$RXRX $VERU The future isn’t one blockbuster drug. The future is combinations. The industry is moving toward a world where finding and optimizing combinations matters as much as inventing the original drug—and that’s a world where large-scale AI biology platforms should have a structural advantage.
0 · Reply
LoveRetailFroth
LoveRetailFroth Jun. 4 at 4:42 PM
$RXRX If SpaceX is worth 2 TRILLION, this & $TEM should be worth atleast 100 Billion 😂
0 · Reply
Bulltrader988
Bulltrader988 Jun. 4 at 4:30 PM
$RXRX Bullish options 👃👀 https://x.com/i/status/2062543917363466448
0 · Reply
Crypto9999
Crypto9999 Jun. 4 at 4:26 PM
$RXRX So, average daily volume is around 15-17 million shares... We're over 27 million already... Yeah, big money is not stepping in and no big news coming...SURE! That said, the wormy market makers will try their hardest to keep this around 4 (due to Option expiration tomorrow) ... Fun to watch...🤑🤑🤑 Shorty..😱😱😱 $5++++🧲🧲🧲🧲
0 · Reply
Zio_Fauss
Zio_Fauss Jun. 4 at 4:25 PM
$RXRX Yes, many options contracts with a $4 strike price expire tomorrow.
0 · Reply
Bulltrader988
Bulltrader988 Jun. 4 at 4:21 PM
$RXRX Heating up 👃👀 https://x.com/i/status/2062544612032454846
0 · Reply
LoveRetailFroth
LoveRetailFroth Jun. 4 at 4:17 PM
$RXRX Gold Man😂🚀
0 · Reply
Spartangio
Spartangio Jun. 4 at 4:08 PM
$RXRX Nice volume
0 · Reply
Tloks
Tloks Jun. 4 at 3:54 PM
0 · Reply
GDoGGT
GDoGGT Jun. 4 at 3:36 PM
For your health! $ZPTA $TEM $RXRX $CAPR Quantum + helathcare discoveries , huzzah!
0 · Reply
Discovery01
Discovery01 Jun. 4 at 3:32 PM
1 · Reply
Hashstockw
Hashstockw Jun. 4 at 3:30 PM
$RXRX lets see it trending @Stocktwits
1 · Reply
Theglove96
Theglove96 Jun. 4 at 3:24 PM
$RXRX we about to blow .. shorts are gonna pay
0 · Reply
LoveRetailFroth
LoveRetailFroth Jun. 4 at 3:17 PM
$RXRX MASA! 50X .com. He owns 3.5 %. His only mistake was selling $NVDA early 😂🚀
0 · Reply